Definitions of terms for reporting adverse drug reactions (IX): Nervous system and psychiatric disorders

Pharmacoepidemiology and Drug Safety

Volumn 7, Issue 1, 1998, Pages 39-49

  Bankowski, Zbigniew ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Anorexia; Anticholinergic syndrome; Apathy; Central and peripheral nervous system terms; Choreoathetosis; Delirium; Depersonalization; Dysphonia; Dystonia; Encephalopathy; Extrapyramidal disorder; Gait abnormal; Hypertonia; Hypotonia; Neuroleptic malignant syndrome; Oculogyric crisis; Personality disorder; Psychiatric disorder terms; Psychosis; Serotonin syndrome; Speech disorder; Thinking abnormal

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; LITHIUM; NEUROLEPTIC AGENT; SCOPOLAMINE; SEROTONIN AGONIST;

ANOREXIA; ANTICHOLINERGIC EFFECT; BRAIN DISEASE; CHOREOATHETOSIS; CONFERENCE PAPER; DEPERSONALIZATION; DYSPHONIA; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; GAIT DISORDER; HUMAN; MENTAL DISEASE; MUSCLE HYPERTONIA; MUSCLE HYPOTONIA; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC DISEASE; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSIS; SEROTONIN SYNDROME; SPEECH DISORDER;

EID: 13144254241     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199801/02)7:1<39::AID-PDS316>3.0.CO;2-Z     Document Type: Conference Paper

References (12)

1. International Reporting of Adverse Drug Reactions. Final Report of CIOMS Working Group, CIOMS, Geneva, 1990.
2. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an International Consensus Meeting. International Journal of Clinical Pharmacology, Therapy and Toxicology 1990; 28(8): 317-322.
3. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia. International Journal of Clinical Pharmacology, Therapy and Toxicology 1991; 29(2): 75-81.
4. Basic requirements for the use of terms for reporting adverse drug reactions. Anaphylactic shock, arrhythmia, cardiac failure, hypertension, thrombosis and embolism. Pharmacoepidemiology and Drug Safety 1992; 1: 39-45.
5. Basic requirements for the use of terms for reporting adverse drug reactions (II). Colitis, gastrointestinal haemorrhage, hepatocellular damage, peptic ulcer, pancreatitis. Pharmacoepidemiology and Drug Safety 1992; 1: 133-137.
6. Basic requirements for the use of terms for reporting adverse drug reactions (III). Aplastic anaemia, bone marrow depression, coagulation disorders, agranulocytosis, thrombophlebitis. Pharmacoepidemiology and Drug Safety 1992; 1: 191-196.
7. Basic requirements for the use of terms for reporting adverse drug reactions (IV). Diskinesia, depression, myopathy, neuropathy, paralysis, convulsions. Pharmacoepidemiology and Drug Safety 1993; 2: 149-153.
8. Basic requirements for the use of terms for reporting adverse drug reactions (V). Vision abnormal, keratitis, cataract, retinal disorder, acidosis. Pharmacoepidemiology and Drug Safety 1993; 2: 189-193.
9. Definition of adverse drug reactions and minimum requirements for their use - cardiovascular disease terms. Pharmacoepidemiology and Drug Safety 1993; 2: 591-602.
10. Basic requirements for the use of terms for reporting adverse drug reactions (VII) - Respiratory disorders and skin disorders. Pharmacoepidemiology and Drug Safety 1996; 5: 115-127.
11. Adverse-Drug-Reaction Terms: Definitions: Respiratory Disorders. Skin Disorders. Geneva, Council for International Organizations of Medical Sciences, 1996.
12. Basic requirements for the use of terms for reporting adverse drug reactions (VIII) - renal and urinary system disorders. Pharmacoepidemiology and Drug Safety 1997; 6: 203-211.